Yonatan Hagai Grad

Yonatan Hagai Grad

Auto-generated profile, based on publicly available information

Yonatan Hagai Grad

Harvard T.H. Chan School of Public Health

Research Focus & Metrics

Academic Career Length

14Years (2013-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
22 May 2020 in Science
Verified
Journal Article
Open access
PDF file
SKStephen M. Kissler
Stephen M. Kissler
CTChristine Tedijanto
Christine Tedijanto
EGEdward Goldstein
Edward Goldstein
YGYonatan H. Grad
Yonatan H. Grad
MLMarc Lipsitch
Marc Lipsitch
What happens next?: Four months into the severe acute respiratory syndrome–coronavirus 2 (SARS-CoV-2) outbreak, we still do not know enough about postrecovery immune protection and environmental and seasonal influences on transmission to predict transmission dynamics accurately. However, we do know that humans are seasonally afflicted by other, less severe coronaviruses. Kissler et al. used existing data to build a deterministic model of multiyear interactions between existing coronaviruses, with a focus on the United States, and used this to project the potential epidemic dynamics and pressures on critical care capacity over the next 5 years. The long-term dynamics of SARS-CoV-2 strongly depends on immune responses and immune cross-reactions between the coronaviruses, as well as the timing of introduction of the new virus into a population. One scenario is that a resurgence in SARS-CoV-2 could occur as far into the future as 2025. Science , this issue p. 860

26 February 2021 in Science
Verified
Journal Article
Open access
PDF file
KBKate M. Bubar
Kate M. Bubar
KRKyle Reinholt
Kyle Reinholt
SKStephen M. Kissler
Stephen M. Kissler
MLMarc Lipsitch
Marc Lipsitch
SCSarah Cobey
Sarah Cobey
DLDaniel B. Larremore
Daniel B. Larremore
Limited initial supply of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) vaccine raises the question of how to prioritize available doses. We used a mathematical model to compare five age-stratified prioritization strategies. A highly effective transmission-blocking vaccine prioritized to adults ages 20 to 49 years minimized cumulative incidence, but mortality and years of life lost were minimized in most scenarios when the vaccine was prioritized to adults greater than 60 years old. Use of individual-level serological tests to redirect doses to seronegative individuals improved the marginal impact of each dose while potentially reducing existing inequities in COVID-19 impact. Although maximum impact prioritization strategies were broadly consistent across countries, transmission rates, vaccination rollout speeds, and estimates of naturally acquired immunity, this framework can be used to compare impacts of prioritization strategies across contexts.

1 December 2021 in New England Journal of Medicine
Verified
Journal Article
Closed access
PDF file
SKStephen M. Kissler
Stephen M. Kissler
JFJoseph R. Fauver
Joseph R. Fauver
CMChristina Mack
Christina Mack
CTCaroline G. Tai
Caroline G. Tai
MBMallery I. Breban
Mallery I. Breban
YGYonatan H. Grad
Yonatan H. Grad
Two opposing forces that are shaping the coronavirus disease 2019 (Covid-19) pandemic are the emergence of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) variants of concern and the uptake of vaccines. Measurement of SARS-CoV-2 viral load over the course of acute infection can inform hypotheses about the mechanisms that underlie variation in transmissibility according to variant and vaccination status.1

28 March 2017 in Proceedings of the National Academy of Sciences
Verified
Journal Article
Closed access
PDF file
CPCorey M. Peak
Corey M. Peak
LCLauren M. Childs
Lauren M. Childs
YGYonatan H. Grad
Yonatan H. Grad
CBCaroline O. Buckee
Caroline O. Buckee
Significance: Quarantine and symptom monitoring of contacts with suspected exposure to an infectious disease are key interventions for the control of emerging epidemics; however, there does not yet exist a quantitative framework for comparing the control performance of each intervention. Here, we use a mathematical model of seven case-study diseases to show how the choice of intervention is influenced by the natural history of the infectious disease, its inherent transmissibility, and the intervention feasibility in the particular healthcare setting. We use this information to identify the most important characteristics of the disease and setting that need to be considered for an emerging pathogen to make an informed decision between quarantine and symptom monitoring.

6 October 2020 in Nature Reviews Immunology
Verified
Journal Article
Closed access
PDF file
MLMarc Lipsitch
Marc Lipsitch
YGYonatan H. Grad
Yonatan H. Grad
Alessandro SetteAlessandro Sette
Alessandro Sette
SCShane Crotty
Shane Crotty

6 August 2018 in Nature Microbiology
Verified
Journal Article
Closed access
PDF file
NHNathan D. Hicks
Nathan D. Hicks
JYJian Yang
Jian Yang
XZXiaobing Zhang
Xiaobing Zhang
BZBing Zhao
Bing Zhao
YGYonatan H. Grad
Yonatan H. Grad
SFSarah M. Fortune
Sarah M. Fortune